Literature DB >> 16701634

The Living & Breathing Study: a study of patients' views of asthma and its treatment.

John Haughney1, Greta Barnes, Martyn Partridge, Jennifer Cleland.   

Abstract

AIM: To evaluate patient understanding of their asthma and determine patient preferences regarding the delivery of asthma care and treatment.
METHODS: Adults with asthma receiving treatment for mild to moderate asthma were recruited to a two-part study: a qualitative phase using a semi-structured interview schedule followed by a quantitative phase based on a structured interview schedule. All interviews were undertaken face-to-face. SETTING AND
SUBJECTS: A random sample of 40 patients with mild to moderate asthma from seven areas of the UK took part in the qualitative phase of the study. In the quantitative phase, 517 patients on treatment for mild to moderate asthma were interviewed in person by market researchers. This population was achieved using a quota sampling approach that also achieved a representative demographic profile. Initial contact was made in door-to-door calls. Interviews took place in 64 locations across the UK.
RESULTS: Ninety-one percent (n=468) of respondents felt their asthma was under control, yet two-thirds (n=339) experienced symptoms at least 2-3 times a week. Only 24% (n=123) felt their asthma could improve over time, and 71% (n=366) received no advice from healthcare professionals on how their asthma might change in the future. Fourteen percent (n=74) of respondents had no ongoing contact with any healthcare professional regarding their asthma. Fifty-eight percent (n=301) were very satisfied with their asthma care, but this dropped to 33% (n=173) when respondents were shown asthma guidelines regarding what to expect from treatment. Sixty-two percent (n=318) of respondents said their asthma varied at different times of the day, and 86% (n=444) stated that their asthma varied at different times of the year. Eighty percent (n=414) of respondents had never been provided with a written, personal asthma action plan recommending changes patients could make themselves to prescribed treatment according to symptom severity, though 68% (n=353) said they would feel comfortable following such a plan.
CONCLUSIONS: Most patients have low expectations of what can be achieved by asthma management and do not realise their condition can be improved. Many are resigned to the effects of poor asthma control until made aware that guidelines indicate this can be better. Given that many are receptive to the notion of written, personal asthma action plans, the implementation of these, supported by appropriate education, could help patients achieve improved asthma control.

Entities:  

Year:  2004        PMID: 16701634      PMCID: PMC6750659          DOI: 10.1016/j.pcrj.2003.11.007

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  42 in total

Review 1.  The paradox of adult asthma control: "who's in control anyway?".

Authors:  Rick Hodder
Journal:  Can Respir J       Date:  2007 May-Jun       Impact factor: 2.409

2.  Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.

Authors:  René Aalbers
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

3.  Barriers to the implementation of self management support in long term lung conditions.

Authors:  N J Roberts; I Younis; L Kidd; M R Partridge
Journal:  London J Prim Care (Abingdon)       Date:  2012

4.  A pragmatic, three-arm randomised controlled trial of spiritual healing for asthma in primary care.

Authors:  Jennifer A Cleland; David B Price; Amanda J Lee; Stan Gerard; Arun Sharma
Journal:  Br J Gen Pract       Date:  2006-06       Impact factor: 5.386

5.  Accessibility, clinical effectiveness, and practice costs of providing a telephone option for routine asthma reviews: phase IV controlled implementation study.

Authors:  Hilary Pinnock; Lorraine Adlem; Suzanne Gaskin; Jan Harris; Caroline Snellgrove; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2007-09       Impact factor: 5.386

Review 6.  Salmeterol/fluticasone propionate: a review of its use in asthma.

Authors:  Kate McKeage; Susan J Keam
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group.

Authors:  Meyer Balter; Pierre Ernst; Wade Watson; Harold Kim; Lisa Cicutto; Marie-France Beauchesne; Andrew J Cave; Alan Kaplan; Donna Hogg; Andrew McIvor; Tom Smiley; Michel Rouleau; J Mark FitzGerald
Journal:  Can Respir J       Date:  2008 Nov-Dec       Impact factor: 2.409

8.  Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD.

Authors:  Louis-Philippe Boulet; Allan Becker; Dennis Bowie; Paul Hernandez; Andrew McIvor; Michel Rouleau; Jean Bourbeau; Ian D Graham; Jo Logan; France Légaré; Thomas F Ward; Robert L Cowie; Denis Drouin; Stewart B Harris; Robyn Tamblyn; Pierre Ernst; Wan C Tan; Martyn R Partridge; Philippe Godard; Carla T Herrerias; John W Wilson; Liz Stirling; Emily-Brynn Rozitis; Nancy Garvey; Diane Lougheed; Manon Labrecque; Renata Rea; Martin C Holroyde; Danielle Fagnan; Eileen Dorval; Lisa Pogany; Alan Kaplan; Lisa Cicutto; Mary L Allen; Serge Moraca; J Mark FitzGerald; Francine Borduas
Journal:  Can Respir J       Date:  2006-03       Impact factor: 2.409

9.  Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids.

Authors:  Tanja T Menckeberg; Marcel L Bouvy; Madelon Bracke; Jacqueline G Hugtenburg; Jan-Willem Lammers; Jan A M Raaijmakers
Journal:  Br J Clin Pharmacol       Date:  2008-08       Impact factor: 4.335

Review 10.  [Asthma among senior adults].

Authors:  U de Vries; F Petermann
Journal:  Internist (Berl)       Date:  2008-11       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.